Role of advanced glycation end-products in obesity-related ovarian dysfunction

Z. Merhi, E. A. McGee, Erkan Buyuk

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Obesity affects ovarian function, one of the main regulators of female fertility. Tissue levels of the proinflammatory advanced glycation end-products (AGEs) and their receptors (RAGE) are elevated in obesity. AGEs are key contributors to perturbations in the ovarian microenvironment. On this basis, the present review focuses on clinical and experimental studies supporting the role of AGE-RAGE system as a contributor to obesity-related ovarian dysfunction. Particular emphasis has been given to changes in AGEs, RAGE and the antiinflammatory soluble receptor (sRAGE) levels in obesity state and following dietary interventions (high-fat diet and weight loss). Ovarian sensitivity, in particular granulosa cell function and oocyte meiosis, to the pro-inflammatory AGE-RAGE system as well as the relationship of follicular fluid AGEs and sRAGE to in vitro fertilization outcome are also discussed. Overall, obesity, with its alterations in the AGE-RAGE system, can disrupt the ovarian microenvironment potentially compromising oocyte competence and fertility. This review underscores a critical need to uncover the mechanistic actions of AGE-RAGE system in obesity-related ovarian dysfunction. Clinical and basic studies focusing on elucidating the patterns of accumulation and role of the AGE-RAGE system in human ovarian follicles are key steps in understanding their contribution to the health of human oocytes and embryos.

Original languageEnglish (US)
Pages (from-to)167-174
Number of pages8
JournalMinerva Endocrinologica
Volume39
Issue number3
StatePublished - Sep 1 2014

Fingerprint

Advanced Glycosylation End Products
Obesity
Oocytes
Fertility
Follicular Fluid
Ovarian Follicle
Granulosa Cells
Meiosis
High Fat Diet
Fertilization in Vitro
Mental Competency
Weight Loss
Anti-Inflammatory Agents
Embryonic Structures
Health

Keywords

  • Advanced glycosylation end-product receptor
  • Glycosylation end products, advanced
  • Obesity
  • Ovary

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Endocrinology
  • Medicine(all)

Cite this

Role of advanced glycation end-products in obesity-related ovarian dysfunction. / Merhi, Z.; McGee, E. A.; Buyuk, Erkan.

In: Minerva Endocrinologica, Vol. 39, No. 3, 01.09.2014, p. 167-174.

Research output: Contribution to journalArticle

Merhi, Z, McGee, EA & Buyuk, E 2014, 'Role of advanced glycation end-products in obesity-related ovarian dysfunction', Minerva Endocrinologica, vol. 39, no. 3, pp. 167-174.
Merhi, Z. ; McGee, E. A. ; Buyuk, Erkan. / Role of advanced glycation end-products in obesity-related ovarian dysfunction. In: Minerva Endocrinologica. 2014 ; Vol. 39, No. 3. pp. 167-174.
@article{05a3f3232ed24bedaacefb7341b101fa,
title = "Role of advanced glycation end-products in obesity-related ovarian dysfunction",
abstract = "Obesity affects ovarian function, one of the main regulators of female fertility. Tissue levels of the proinflammatory advanced glycation end-products (AGEs) and their receptors (RAGE) are elevated in obesity. AGEs are key contributors to perturbations in the ovarian microenvironment. On this basis, the present review focuses on clinical and experimental studies supporting the role of AGE-RAGE system as a contributor to obesity-related ovarian dysfunction. Particular emphasis has been given to changes in AGEs, RAGE and the antiinflammatory soluble receptor (sRAGE) levels in obesity state and following dietary interventions (high-fat diet and weight loss). Ovarian sensitivity, in particular granulosa cell function and oocyte meiosis, to the pro-inflammatory AGE-RAGE system as well as the relationship of follicular fluid AGEs and sRAGE to in vitro fertilization outcome are also discussed. Overall, obesity, with its alterations in the AGE-RAGE system, can disrupt the ovarian microenvironment potentially compromising oocyte competence and fertility. This review underscores a critical need to uncover the mechanistic actions of AGE-RAGE system in obesity-related ovarian dysfunction. Clinical and basic studies focusing on elucidating the patterns of accumulation and role of the AGE-RAGE system in human ovarian follicles are key steps in understanding their contribution to the health of human oocytes and embryos.",
keywords = "Advanced glycosylation end-product receptor, Glycosylation end products, advanced, Obesity, Ovary",
author = "Z. Merhi and McGee, {E. A.} and Erkan Buyuk",
year = "2014",
month = "9",
day = "1",
language = "English (US)",
volume = "39",
pages = "167--174",
journal = "Minerva Endocrinologica",
issn = "0391-1977",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Role of advanced glycation end-products in obesity-related ovarian dysfunction

AU - Merhi, Z.

AU - McGee, E. A.

AU - Buyuk, Erkan

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Obesity affects ovarian function, one of the main regulators of female fertility. Tissue levels of the proinflammatory advanced glycation end-products (AGEs) and their receptors (RAGE) are elevated in obesity. AGEs are key contributors to perturbations in the ovarian microenvironment. On this basis, the present review focuses on clinical and experimental studies supporting the role of AGE-RAGE system as a contributor to obesity-related ovarian dysfunction. Particular emphasis has been given to changes in AGEs, RAGE and the antiinflammatory soluble receptor (sRAGE) levels in obesity state and following dietary interventions (high-fat diet and weight loss). Ovarian sensitivity, in particular granulosa cell function and oocyte meiosis, to the pro-inflammatory AGE-RAGE system as well as the relationship of follicular fluid AGEs and sRAGE to in vitro fertilization outcome are also discussed. Overall, obesity, with its alterations in the AGE-RAGE system, can disrupt the ovarian microenvironment potentially compromising oocyte competence and fertility. This review underscores a critical need to uncover the mechanistic actions of AGE-RAGE system in obesity-related ovarian dysfunction. Clinical and basic studies focusing on elucidating the patterns of accumulation and role of the AGE-RAGE system in human ovarian follicles are key steps in understanding their contribution to the health of human oocytes and embryos.

AB - Obesity affects ovarian function, one of the main regulators of female fertility. Tissue levels of the proinflammatory advanced glycation end-products (AGEs) and their receptors (RAGE) are elevated in obesity. AGEs are key contributors to perturbations in the ovarian microenvironment. On this basis, the present review focuses on clinical and experimental studies supporting the role of AGE-RAGE system as a contributor to obesity-related ovarian dysfunction. Particular emphasis has been given to changes in AGEs, RAGE and the antiinflammatory soluble receptor (sRAGE) levels in obesity state and following dietary interventions (high-fat diet and weight loss). Ovarian sensitivity, in particular granulosa cell function and oocyte meiosis, to the pro-inflammatory AGE-RAGE system as well as the relationship of follicular fluid AGEs and sRAGE to in vitro fertilization outcome are also discussed. Overall, obesity, with its alterations in the AGE-RAGE system, can disrupt the ovarian microenvironment potentially compromising oocyte competence and fertility. This review underscores a critical need to uncover the mechanistic actions of AGE-RAGE system in obesity-related ovarian dysfunction. Clinical and basic studies focusing on elucidating the patterns of accumulation and role of the AGE-RAGE system in human ovarian follicles are key steps in understanding their contribution to the health of human oocytes and embryos.

KW - Advanced glycosylation end-product receptor

KW - Glycosylation end products, advanced

KW - Obesity

KW - Ovary

UR - http://www.scopus.com/inward/record.url?scp=84913543870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84913543870&partnerID=8YFLogxK

M3 - Article

C2 - 25068304

AN - SCOPUS:84913543870

VL - 39

SP - 167

EP - 174

JO - Minerva Endocrinologica

JF - Minerva Endocrinologica

SN - 0391-1977

IS - 3

ER -